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Abstract 
Objective:  To determine efficacy of oral iron therapy as 
compared to parentral iron therapy. 
Study design and duration: This is a prospective study 
of observational type. Study consists on the duration of 5 
months. 
Setting: This study was conducted in Bahawal Victoria 
Hospital Bahawalpur. 
Patients and Methods:  Anemic patients having Hb less 
than 10g/dl were included in this study. Two groups were 
formed group-A and group-B. Group-A was given oral 
iron therapy while group-B was given Intravenous iron 
therapy and outcome was noted after 30 days and 60 
days in the form of hemoglobin level, hematochrit and 
MCV values. All data collected was analyzed using 
SPSS and Microsoft office version 2016. Results were 
calculated in the form of frequencies and percentages and 
averages. Tables and Graphs used to present data. 
Consent was taken from ethical committee of the study 
hospital and consent was also taken from all cases in 
study group.  
Results:  There were total 70 cases in study group 
selected via randomized controlled trials. There were two 
groups containing 35 in each group. In group-A after 60 
days of iron therapy via oral route HB value was 10.7 
g/dl and after 60 days 11.8g/dl with the change of 22.4% 
in HB level. In Group-B after 60 days of intravenous iron 
therapy HB level was 12.9 g/dl with improvement of 
38.8% in HB level. P- Value was 0.05. Age range of 
cases was 15-35 years of age with mean age of 31.4 
years. Baseline characteristics of cases in group-A were 
age 33±4 years, BMI 23±5, HB level was 9.2±1 g/dl, 
Hematochrit (HCT) was 29.5±3 and MCV was 72±0.6. 
In group B mean age was 34±3, BMI 21±2, HB level 
9.2±0.5, Hct was 28.6±3.4, MCV was 70±4.    
Conclusion:  Parentral route of iron therapy is more 
effective in post partum period in women than oral route 
with more improvement in blood hemoglobin, 
hematochrit and MCV value.   
Key Words:  iron therapy,  Oral route, Parentral 
route, Hemoglobin, hematochrit, post partum 
period 
Introduction 
Women in post partum period usually develop 
anemia due to blood loss and in 30% cases Hb 
level is less than 10g/dl. Anemia is defined as 
decreased in hemoglobin concentration and Hct as 
well. Severe anemia with Hb less than 8g/dl is 
found in 10% cases in post partum period. In 
pregnancy WHO defines anemia as Hb level less 
than 11g/dl in first and 3rd trimester and less than 
10.5g/dl in 2nd trimester. It is a very common 
problem worldwide. Iron deficiency anemia in 
pregnancy is very common. During pregnancy 
maternal red cell mass is increased and 
fetoplacental demand for iron is increased as well 
leading to development of iron deficiency anemia. 
Iron deficiency during pregnancy and blood loss 
during delivery cause severe anemia in women and 
increasing demand for iron therapy. Iron therapy 
can be given via oral as well as parenral route. Oral 
route is not much effective as compared to 
intravenous route due to absorption factor through 
intestine. Intravenous iron therapy is very effective 
in incrrasing hemoglobin and Hct level so 
correcting anemia in one to two months. 
Patients and Methods 
This is a prospective study in which effect of iron 
therapy is observed in two groups of patients. This 
study was started in January 2019 and completed in 
May 2019 consisting on total duration of 5 months. 
This study was conducted in a tertiary care hospital 
Bahawal Victoria Hospital located in Bahawalpur, 
A city of Pakistan. Anemic patients having Hb less 
than 10g/dl were included in this study. Two 
groups were formed group-A and group-B. Group-
A was given oral iron therapy while group-B was 
given Intravenous iron therapy and outcome was 
noted after 30 days and 60 days in the form of 
hemoglobin level, hematochrit and MCV values. 
All data collected was analyzed using SPSS and 
Microsoft office version 2016. Results were 
calculated in the form of frequencies and 
percentages and averages. Tables and Graphs used 
to present data. Consent was taken from ethical 
committee of the study hospital and consent was 
also taken from all cases in study group.  
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Results 
There were total 70 cases in study group selected 
via randomized controlled trials. There were two 
groups containing 35 in each group. In group-A 
after 60 days of iron therapy via oral route HB 
value was 10.7 g/dl and after 60 days 11.8g/dl with 
the change of 22.4% in HB level. In Group-B after 
60 days of intravenous iron therapy HB level was 
12.9 g/dl with improvement of 38.8% in HB level. 
P- Value was 0.05. Age range of cases was 15-35 
years of age with mean age of 31.4 years. This is a 
prospective study in which effect of iron therapy is 
observed in two groups of patients. This study was 
started in January 2019 and completed in May 
2019 consisting on total duration of 5 months. This 
study was conducted in a tertiary care hospital 
Bahawal Victoria Hospital located in Bahawalpur, 
A city of Pakistan. Anemic patients having Hb less 
than 10g/dl were included in this study. Two 
groups were formed group-A and group-B. Group-
A was given oral iron therapy while group-B was 
given Intravenous iron therapy and outcome was 
noted after 30 days and 60 days in the form of 
hemoglobin level, hematochrit and MCV 
valuesBaseline characteristics of cases in group-A 
were age 33±4 years, BMI 23±5, HB level was 
9.2±1 g/dl, Hematochrit (HCT) was 29.5±3 and 
MCV was 72±0.6. In group B mean age was 34±3, 
BMI 21±2, HB level 9.2±0.5, Hct was 28.6±3.4, 
MCV was 70±4.    
 
 
(Figure-1) Improvement in Hemoglobin via oral vs parentral route 
DISCUSSION 
In women during pregnancy and after delivery 
anemia develops due to iron deficiency. This 
anemia needs to be corrected either in the form of 
oral iron therapy or intravenous therapy. Oran iron 
is not completely absorbed and many factors 
decrease its absorption so results are not much 
satisfactory. Iron given via intravenous route is 
much effective as 100% bioavailability and its 
rapid response corrects anemia within days. 
Usually iron is available in the form of tablets and 
injection ampoules which are mixed in fluid and 
given slowly intravenously. Intravenous iron may 
cause reaction so initially it is given very slowly to 
check any reaction. Women in post partum period 
usually develop anemia due to blood loss and in 
30% cases Hb level is less than 10g/dl. Anemia is 
defined as decreased in hemoglobin concentration 
and Hct as well. There were total 70 cases in study 
group selected via randomized controlled trials. 
There were two groups containing 35 in each 
group. In group-A after 60 days of iron therapy via 
oral route HB value was 10.7 g/dl and after 60 days 
11.8g/dl with the change of 22.4% in HB level. In 
Group-B after 60 days of intravenous iron therapy 
HB level was 12.9 g/dl with improvement of 38.8% 
in HB level. P- Value was 0.05. Age range of cases 
was 15-35 years of age with mean age of 31.4 
years. Severe anemia with Hb less than 8g/dl is 
found in 10% cases in post partum period. In 
pregnancy WHO defines anemia as Hb level less 
than 11g/dl in first and 3rd trimester and less than 
10.5g/dl in 2nd trimester. This is a prospective study 
in which effect of iron therapy is observed in two 
groups of patients. This study was started in 
January 2019 and completed in May 2019 
consisting on total duration of 5 months. This study 
was conducted in a tertiary care hospital Bahawal 
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Victoria Hospital located in Bahawalpur, A city of 
Pakistan. Anemic patients having Hb less than 
10g/dl were included in this study. Two groups 
were formed group-A and group-B. It is a very 
common problem worldwide. Iron deficiency 
anemia in pregnancy is very common. During 
pregnancy maternal red cell mass is increased and 
fetoplacental demand for iron is increased as well 
leading to development of iron deficiency anemia. . 
All data collected was analyzed using SPSS and 
Microsoft office version 2016. Results were 
calculated in the form of frequencies and 
percentages and averages. Tables and Graphs used 
to present data. Consent was taken from ethical 
committee of the study hospital and consent was 
also taken from all cases in study group. Iron 
deficiency during pregnancy and blood loss during 
delivery cause severe anemia in women and 
increasing demand for iron therapy. Iron therapy 
can be given via oral as well as parenral route.   
Conclusion 
Iron given intravenously corrects anemia rapidly as 
compared to orally given. It improves hemoglobin, 
hematochrit and MCV effectively. Oral iron 
therapy is less effective due to non-compliance, 
less bioavailability and more side effects. 
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